LifeStance Health (LFST) Cash & Current Investments (2020 - 2026)

LifeStance Health has disclosed Cash & Current Investments across 7 years of filings, most recently posting $76.9 million for Q1 2026.

• In Q1 2026, Cash & Current Investments fell 43.09% year-over-year to $76.9 million; the TTM figure through Mar 2026 stood at $76.9 million (down 43.09% YoY), while the FY2025 annual figure was $175.5 million, up 43.68% from the prior year.
• Cash & Current Investments declined to $76.9 million in Q1 2026, from $175.5 million in the prior quarter.
• Over the last five years, Cash & Current Investments for LFST reached as high as $175.5 million in Q4 2025 and fell as low as $34.4 million in Q3 2023.
• The 5-year median for Cash & Current Investments is $113.0 million (2022), against an average of $105.0 million.
• Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 71.04% — and 2025, when it surged 272.27%.
• A 5-year view of Cash & Current Investments shows it stood at $113.0 million in 2022, then slumped by 37.52% to $70.6 million in 2023, then jumped by 72.96% to $122.2 million in 2024, then jumped by 43.68% to $175.5 million in 2025, then tumbled by 56.17% to $76.9 million in 2026.
• According to Business Quant data, Cash & Current Investments over the past three periods registered $76.9 million, $175.5 million, and $141.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.